A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
NCT00441337
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Non-Small-Cell Lung
Colorectal Cancer
Malignant Melanoma
Renal Cancer
Prostate Cancer
Interventions
BIOLOGICAL:
MDX-1106
Sponsor
Bristol-Myers Squibb